APOE and Alzheimer disease: Additionally, a considerable body of evidence indicates that APOE ε4 allele, a well-known AD risk factor, increases the risk of severity and mortality of COVID-19, independent of pre-existing dementia, cardiovascular disease, and type-2 diabetes [147–149].